Comparison of health care utilization and costs in type 2 diabetes patients initiating analog and human insulins

被引：0
|
作者：
Margolis, J. [1 ]
Johnson, B. H. [2 ]
Chu, B. C. [3 ]
Forma, F. [4 ]
Alemayehu, B. [4 ]
机构：
[1] Thomson Healthcare, Washington, DC USA
[2] Thomson Healthcare, Cambridge, MA USA
[3] Thomson Healthcare, Santa Barbara, CA USA
[4] Novo Nordisk Inc, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70752-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A237 / A238
页数：2
相关论文
共 50 条
  • [21] A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
    Lin Xie
    Wenhui Wei
    Chunshen Pan
    Juan Du
    Onur Baser
    Advances in Therapy, 2011, 28 : 1000 - 1011
  • [22] A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
    Xie, Lin
    Wei, Wenhui
    Pan, Chunshen
    Du, Juan
    Baser, Onur
    ADVANCES IN THERAPY, 2011, 28 (11) : 1000 - 1011
  • [23] Health-Care Utilization and Costs in Patients Initiating Exenatide Once Weekly Compared with Insulin Glargine
    Kong, Amanda M.
    Wittbrodt, Eric
    Moore-Schiltz, Laura
    Juneau, Paul
    DIABETES, 2017, 66 : A362 - A362
  • [24] HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS INITIATING NATALIZUMAB THERAPY FOR MULTIPLE SCLEROSIS IN THE UNITED STATES
    Johnson, B. H.
    Bonafede, M.
    Watson, C.
    VALUE IN HEALTH, 2013, 16 (03) : A104 - A104
  • [25] HEALTH CARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH VARIOUS STAGES OF CHRONIC KIDNEY DISEASE AMONG TYPE 2 DIABETES MELLITUS PATIENTS
    Chuang, C. C.
    Lee, E.
    Yang, E.
    Tawah, A.
    Ghosh, S.
    Chen, S. Y.
    VALUE IN HEALTH, 2014, 17 (03) : A244 - A245
  • [26] HEALTH CARE RESOURCE UTILIZATION AND COSTS OF PATIENTS WITH TYPE 2 DIABETES TREATED WITH DULAGLUTIDE VS. EXENATIDE QW OR LIRAGLUTIDE IN THE US
    Mody, R.
    Alatorre, C.
    Yu, M.
    Lando, Fernandez L.
    Davis, B.
    Juneau, P.
    VALUE IN HEALTH, 2017, 20 (05) : A178 - A178
  • [27] Comparison of 12-Month Adherence and Health Care Costs between Patients with Type 2 Diabetes Mellitus Newly Initiating Liraglutide QD or Exenatide QW in US Clinical Practice
    Johnston, Stephen
    Nguyen, Hiep
    Cappell, Katherine
    Nelson, James
    Chu, Bong-Chul
    Kalsekar, Iftekhar
    DIABETES, 2015, 64 : A289 - A289
  • [28] LONG-TERM HEALTH CARE COSTS AMONG ADULTS WITH TYPE 2 DIABETES INITIATING DPP-4 INHIBITORS
    Farr, A. M.
    Sheehan, J.
    Brouillette, M.
    Smith, D. M.
    Johnston, S.
    Kalsekar, I
    VALUE IN HEALTH, 2015, 18 (03) : A8 - A8
  • [29] Reduced Health Care Costs with Automated Basal Insulin Titration in Patients with Type 2 Diabetes
    Sieber, Jochen
    Bajaj, Harpreet S.
    Kottmann, Tanja
    Venn, Karri
    Aronson, Ronnie
    Flacke, Frank
    DIABETES, 2017, 66 : A354 - A354
  • [30] The Importance of Heart Failure on the Outcomes and Health Care Costs of Medicare Patients with Type 2 Diabetes
    Hyland, Kristen A.
    Greiner, Melissa
    Qualls, Laura
    Dunham, Ashley A.
    Hernandez, Adrian
    Miranda, Marie L.
    Califf, Robert
    Curtis, Lesley
    DIABETES, 2014, 63 : A348 - A348
12345